P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

• J. Hwee,
• N. Kwon,
• R. Alfonso-Cristancho,
• L. Baylis,
• G. Requena,
• S. Du,
• A. Khanal,
• L. Huynh,
• M. S. Duh,
• R. W. Jakes

Affiliations

J. Hwee

1 Value Evidence & Outcomes, GSK, Mississauga, ON, Canada

N. Kwon

2 Respiratory Research & Development, GSK, Brentford, Middlesex, United Kingdom

R. Alfonso-Cristancho

3 Value Evidence & Outcomes, GSK, Collegeville, PA, United States of America

L. Baylis

4 Global Medical Affairs, GSK, Durham, NC, United States of America

G. Requena

5 Epidemiology, GSK, London, United Kingdom

S. Du

6 Analysis Group, Inc., Boston, MA, United States of America

A. Khanal

6 Analysis Group, Inc., Boston, MA, United States of America

L. Huynh

6 Analysis Group, Inc., Boston, MA, United States of America

M. S. Duh

6 Analysis Group, Inc., Boston, MA, United States of America

R. W. Jakes

5 Epidemiology, GSK, London, United Kingdom